| |
| |
|
| Insider
Information: |
Cohen Joshua B |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,202,852 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,202,852 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
3,202,852 |
2022-01-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2024-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
179,850 |
3,202,852 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2024-03-05 |
4 |
S |
$18.73 |
$77,440 |
D/D |
(4,135) |
3,023,002 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
126,667 |
3,027,137 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2024-01-09 |
4 |
S |
$16.33 |
$95,372 |
D/D |
(5,841) |
2,900,470 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2023-11-16 |
4 |
OE |
$1.57 |
$100,000 |
D/D |
63,694 |
2,906,311 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2023-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
2,842,617 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2023-03-16 |
4 |
AS |
$31.84 |
$3,186,336 |
D/D |
(100,000) |
2,792,617 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2023-01-06 |
4 |
S |
$36.08 |
$216,629 |
D/D |
(5,968) |
2,892,617 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
2,564,065 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Co-Chief Executive Officer |
• • – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,870 |
2,489,065 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
